San Francisco, CA · Founded 2014 · Privately Held (backing)
Developer of novel B-cell therapies and drugs designed to address significant unmet clinical needs of autoimmunity. BioGraph 55 is based in San Francisco, CA and was founded in 2014. Its last known valuation is $25 million. It has raised $20.1 million.
Last price · $/share
—
Implied valuation
$25.0M
Total raised
$20.1M
Last round
—
Cap table — not yet on record
BioGraph 55's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioGraph 55 with a free account
·Watch BioGraph 55: the Monday email on marks, rounds and moves
